ACTRN12618001489280已完成未知
A Heuristic Approach to determine the optimal method of Heparin Dosing and Reversal in all Patients Undergoing Anaesthesia for Catheter Ablation for Atrial Fibrillation (CA-AF)'
Philip Cumpston0 个研究点目标入组 710 人开始时间: 2018年9月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 710
研究概览
简要总结
Retrospective analysis of data collected during catheter ablation procedures showed that when the I-SDtat 1 activated clotting time device was used, an ACT of 300 or more could be achieved with a single dose of heparin. The ACT after a single dose of protamine was close to the pre-heparin ACT over 90% of the time
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20 Years 至 o limit（—）
- 性别
- All
入选标准
- •All patients presenting for catheter ablation for atrial fibrillation, or implantation of a left atrial occlusion device.
排除标准
- •Known allergic response to heparin. In this case, heparin will not be used.
- •Known history of heparin induced thrombosis/thrombocytopenia
研究者
相似试验
Unknown
不适用
Evaluation of Optimal Ablation Index for Pulmonary Vein Isolation in Patients With AF Prospective RegistryAtrial FibrillationNCT03389074Seoul National University Hospital70
已完成
不适用
Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone ClinicsMethamphetamine AbuseOpioid-use DisorderHIV SeropositivityNCT04706624Hanoi Medical University667
尚未招募
不适用
Establishment of the appropriate method for recording pain-related potentials by intra-epidermal electrical stimulatioHealthy peopleJPRN-UMIN000043574Department of Neurology, Graduate School of Medicine, Chiba University30
已完成
不适用
Catheter Ablation RegistryCardiovascular DiseasesHeart DiseasesArrhythmiaNCT00005195National Heart, Lung, and Blood Institute (NHLBI)
Unknown
不适用
Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory StudyNSCLC Stage IVNSCLC Stage IIIBNCT03594682Beijing Chest Hospital31